...
首页> 外文期刊>International journal of colorectal disease. >The predictive value of metabolic response to preoperative radiochemotherapy in locally advanced rectal cancer measured by PET/CT.
【24h】

The predictive value of metabolic response to preoperative radiochemotherapy in locally advanced rectal cancer measured by PET/CT.

机译:PET / CT测量对局部晚期直肠癌术前放化疗的代谢反应的预测价值。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: To evaluate the value of positron emission tomography using fluorodeoxyglucose and computer tomography scan (FDG-PET/CT) for prediction of histopathological response of preoperative radiochemotherapy (RCTX) in patients with rectal carcinoma. METHODS: Thirty patients with uT3 rectal carcinoma were examined by FDG-PET/CT at baseline, 14 days after initiation, and after completion of preoperative RCTX. The FDG decreases seen with PET scanning from baseline to day 14 (early metabolic response) and after completion of therapy (late metabolic response) were compared with histopathological tumor response. One patient denied surgery after RCTX. RESULTS: The mean (+/-SD) reduction of tumor FDG uptake in histopathologically responding compared to non-responding tumors was -44.3% (+/-20.1%) versus -29.6% (+/-13.1%) (p = 0.085) at day 14 and -66.0% (+/-20.3%) versus -48.3% (+/-23.4%) (p = 0.040) after completion of RCTX. Best differentiation of histopathological tumor response was achieved by a cut-offvalue of 35% reduction of initial FDG uptake at day 14 and 57.5% after completion of therapy. Applying the cut-off values as a criterion for metabolic response, histopathological response was predicted with a sensitivity of 74% (14/19) at day 14 and 79% (15/19) after completion of therapy. The positive predictive value for early metabolic response was 82% (14/17) and for late metabolic response was 83% (15/18). Histopathological evidence of accumulated peritumoral inflammation cells was associated with a minor FDG decrease in five histopathologically responding patients, and influenced the results with negative predictive values of 58% (7/12) and 64% (7/11) at the early and late time points, respectively. CONCLUSIONS: Metabolic response to a preoperative RCTX using FDG-PET/CT in rectal cancer patients can be correlated with histopathological response, but FDG uptake of peritumoral inflammation cells limited the results and led to false negative results.
机译:背景:评价使用氟脱氧葡萄糖和计算机断层扫描(FDG-PET / CT)进行正电子发射断层扫描对直肠癌患者术前放化疗(RCTX)的组织病理学反应的预测价值。方法:30例uT3直肠癌患者在开始时,术后14天以及术前RCTX完成后,均通过FDG-PET / CT检查。从基线到第14天用PET扫描(早期代谢反应)和完成治疗后(晚期代谢反应)观察到的FDG降低与组织病理学肿瘤反应进行比较。一名患者拒绝接受RCTX手术。结果:与无反应的肿瘤相比,在组织病理学反应中,肿瘤FDG摄取的平均(+/- SD)降低为-44.3%(+/- 20.1%)对-29.6%(+/- 13.1%)(p = 0.085 )在RCTX完成后的第14天和-66.0%(+/- 20.3%)对-48.3%(+/- 23.4%)(p = 0.040)。通过在第14天将初始FDG摄取的降低阈值降低35%,并在完成治疗后降低57.5%的阈值,可以实现组织病理学肿瘤反应的最佳区分。应用临界值作为代谢反应的标准,预测组织病理学反应在治疗第14天的敏感度为74%(14/19),完成治疗后的敏感性为79%(15/19)。早期代谢反应的阳性预测值为82%(14/17),晚期代谢反应的阳性预测值为83%(15/18)。累积的肿瘤周围炎症细胞的组织病理学证据与5例组织病理学应答患者的FDG轻度降低有关,并且在早期和晚期,阴性预测值分别为58%(7/12)和64%(7/11)对结果产生影响。点。结论:FDG-PET / CT对直肠癌患者术前RCTX的代谢反应可能与组织病理学反应相关,但是FDG对肿瘤周围炎症细胞的摄取限制了结果,并导致假阴性结果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号